MEI Pharma News

MEI Pharma | 4: Statement of changes in beneficial ownership of securities-Director Wood Steven D

May 21 15:05

MEI Pharma | 8-K: Current report

May 21 12:05

MEI Pharma | 4: Statement of changes in beneficial ownership of securities-Director Flynn James P

May 20 15:01

MEI Pharma | 10-Q: Quarterly report

May 9 15:05

MEI Pharma | 8-K: MEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational Highlights

May 9 15:03

MEI Pharma | EFFECT: Others

Feb 29 05:08

MEI Pharma | 424B5: Prospectus

Feb 28 15:10

MEI Pharma | CORRESP: CORRESP

Feb 26 12:10

MEI Pharma | UPLOAD: Others

Feb 23 12:09

MEI Pharma | 8-K: Current report

Feb 21 15:02

MEI Pharma | S-3: Registration statement for specified transactions by certain issuers

Feb 20 16:39

MEI Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-TANG CAPITAL PARTNERS, LP(4.9%),Tang Capital Management, LLC(4.9%), etc.

Feb 14 15:03

MEI Pharma | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(5.85%)

Feb 13 21:44

MEI Pharma | 8-K: MEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational Highlights

Feb 13 17:06

MEI Pharma | 10-Q: Quarterly report

Feb 13 16:10

MEI Pharma | 8-K: Current report

Jan 16 23:00

MEI Pharma | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Flynn James P

Jan 11 23:00

MEI Pharma | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Wood Steven D

Jan 11 23:00

MEI Pharma | 8-K: Current report

Dec 25, 2023 23:00

MEI Pharma | 8-K: Current report

Dec 22, 2023 15:00